Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: Q4QE52
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 95 | 97 | PF00675 | 0.469 |
CLV_PCSK_FUR_1 | 93 | 97 | PF00082 | 0.481 |
CLV_PCSK_KEX2_1 | 50 | 52 | PF00082 | 0.393 |
CLV_PCSK_KEX2_1 | 95 | 97 | PF00082 | 0.476 |
CLV_PCSK_PC1ET2_1 | 50 | 52 | PF00082 | 0.393 |
CLV_PCSK_SKI1_1 | 50 | 54 | PF00082 | 0.480 |
CLV_PCSK_SKI1_1 | 74 | 78 | PF00082 | 0.502 |
CLV_PCSK_SKI1_1 | 85 | 89 | PF00082 | 0.545 |
DOC_PP1_RVXF_1 | 54 | 61 | PF00149 | 0.511 |
DOC_PP4_FxxP_1 | 23 | 26 | PF00568 | 0.577 |
DOC_PP4_FxxP_1 | 60 | 63 | PF00568 | 0.442 |
DOC_USP7_MATH_1 | 26 | 30 | PF00917 | 0.632 |
DOC_WW_Pin1_4 | 104 | 109 | PF00397 | 0.548 |
DOC_WW_Pin1_4 | 11 | 16 | PF00397 | 0.474 |
DOC_WW_Pin1_4 | 18 | 23 | PF00397 | 0.451 |
DOC_WW_Pin1_4 | 31 | 36 | PF00397 | 0.421 |
LIG_Actin_WH2_2 | 62 | 79 | PF00022 | 0.455 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.641 |
LIG_CSL_BTD_1 | 105 | 108 | PF09270 | 0.551 |
LIG_FHA_1 | 53 | 59 | PF00498 | 0.481 |
LIG_FHA_1 | 86 | 92 | PF00498 | 0.356 |
LIG_LIR_Apic_2 | 21 | 26 | PF02991 | 0.564 |
LIG_LIR_Nem_3 | 14 | 20 | PF02991 | 0.546 |
LIG_PDZ_Class_2 | 123 | 128 | PF00595 | 0.440 |
LIG_SH2_PTP2 | 17 | 20 | PF00017 | 0.564 |
LIG_SH2_STAP1 | 45 | 49 | PF00017 | 0.464 |
LIG_SH2_STAT5 | 112 | 115 | PF00017 | 0.486 |
LIG_SH2_STAT5 | 17 | 20 | PF00017 | 0.572 |
LIG_SH2_STAT5 | 45 | 48 | PF00017 | 0.492 |
LIG_SH3_3 | 102 | 108 | PF00018 | 0.518 |
MOD_CDC14_SPxK_1 | 21 | 24 | PF00782 | 0.404 |
MOD_CDK_SPK_2 | 104 | 109 | PF00069 | 0.548 |
MOD_CDK_SPK_2 | 11 | 16 | PF00069 | 0.524 |
MOD_CDK_SPxK_1 | 18 | 24 | PF00069 | 0.389 |
MOD_CK1_1 | 11 | 17 | PF00069 | 0.492 |
MOD_CK2_1 | 38 | 44 | PF00069 | 0.535 |
MOD_GlcNHglycan | 88 | 91 | PF01048 | 0.492 |
MOD_GSK3_1 | 26 | 33 | PF00069 | 0.591 |
MOD_GSK3_1 | 7 | 14 | PF00069 | 0.567 |
MOD_GSK3_1 | 95 | 102 | PF00069 | 0.602 |
MOD_NEK2_1 | 122 | 127 | PF00069 | 0.582 |
MOD_NEK2_1 | 6 | 11 | PF00069 | 0.518 |
MOD_NEK2_1 | 76 | 81 | PF00069 | 0.447 |
MOD_PIKK_1 | 99 | 105 | PF00454 | 0.521 |
MOD_PKA_1 | 95 | 101 | PF00069 | 0.475 |
MOD_PKA_2 | 95 | 101 | PF00069 | 0.475 |
MOD_PKB_1 | 93 | 101 | PF00069 | 0.480 |
MOD_Plk_1 | 122 | 128 | PF00069 | 0.514 |
MOD_Plk_1 | 43 | 49 | PF00069 | 0.500 |
MOD_Plk_4 | 77 | 83 | PF00069 | 0.573 |
MOD_Plk_4 | 8 | 14 | PF00069 | 0.472 |
MOD_ProDKin_1 | 104 | 110 | PF00069 | 0.548 |
MOD_ProDKin_1 | 11 | 17 | PF00069 | 0.476 |
MOD_ProDKin_1 | 18 | 24 | PF00069 | 0.462 |
MOD_ProDKin_1 | 31 | 37 | PF00069 | 0.419 |
TRG_ENDOCYTIC_2 | 17 | 20 | PF00928 | 0.593 |
TRG_ER_diArg_1 | 92 | 95 | PF00400 | 0.475 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P845 | Leptomonas seymouri | 68% | 96% |
A0A0S4J864 | Bodo saltans | 36% | 99% |
A0A1X0NSP0 | Trypanosomatidae | 52% | 100% |
A0A3R7MB48 | Trypanosoma rangeli | 52% | 100% |
A0A3S7WUQ8 | Leishmania donovani | 91% | 99% |
A4H994 | Leishmania braziliensis | 85% | 99% |
A4HXL5 | Leishmania infantum | 91% | 99% |
C9ZPA9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 54% | 100% |
E9ARB1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 99% |